Proton Intelligence
Vancouver, Canada
Hyperkalemia (high potassium) affects more than 3.7M Americans. Chronic Kidney Disease is the main cause & heart attacks are the main effect. For people at risk of hyperkalemia, potassium needs to be tightly monitored, even during treatment. Today, there is no on-demand K+ monitoring capability to guide treatment of hyperkalemia. Proton Intelligence is building the first real-time, on-demand potassium monitoring wearable, allowing clinicians to treat and manage kidney disease patients more safely and precisely.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2020
- Website
- www.protonintelligence.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Proton Intelligence?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now